2022 |
Feurstein, S., Hahn, C. N., Mehta, N., & Godley, L. A. (2022). A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopenias. Genetics in Medicine, 24(4), 931-954. DOI Scopus2 WoS2 Europe PMC1 |
2022 |
Byrne, A. B., Brouillard, P., Sutton, D. L., Kazenwadel, J., Montazaribarforoushi, S., Secker, G. A., . . . Harvey, N. L. (2022). Pathogenic variants in MDFIC cause recessive central conducting lymphatic anomaly with lymphedema. Science Translational Medicine, 14(634), eabm4869-1-eabm4869-15. DOI Scopus2 WoS2 Europe PMC2 |
2022 |
Drazer, M. W., Homan, C. C., Yu, K., de Andrade Silva, M. C., McNeely, K. E., Pozsgai, M. J., . . . Godley, L. A. (2022). Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations. Blood Advances, 6(15), 4357-4359. DOI Scopus1 |
2022 |
Samaraweera, S. E., Geukens, T., Casolari, D. A., Nguyen, T., Sun, C., Bailey, S., . . . Ross, D. M. (2022). Novel modes of MPL activation in triple-negative myeloproliferative neoplasms. Pathology, 55(1), 9 pages. DOI |
2022 |
Baranwal, A., Hahn, C. N., Shah, M. V., & Hiwase, D. K. (2022). Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms. Current Hematologic Malignancy Reports, 17(6), 254-265. DOI Scopus1 |
2022 |
Saygin, C., Roloff, G. W., Hahn, C. N., Chhetri, R., Gill, S. I., Elmariah, H., . . . Godley, L. A. (2022). Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies.. Blood advances, bloodadvances.2022008172. DOI |
2022 |
Feurstein, S., Luo, X., Shah, M., Walker, T., Mehta, N., Wu, D., . . . Zhang, L. (2022). Revision of RUNX1 variant curation rules. Blood Advances, 6(16), 4726-4730. DOI |
2022 |
Hiwase, D. K., Hahn, C. N., Tran, E. N. H., Chhetri, R., Baranwal, A., Al-Kali, A., . . . Shah, M. V. (2022). TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.. Blood, blood.2022018236. DOI |
2021 |
Singhal, D., Hahn, C. N., Feurstein, S., Wee, L. Y. A., Moma, L., Kutyna, M. M., . . . Hiwase, D. K. (2021). Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer. Leukemia, 35(11), 3245-3256. DOI Scopus20 WoS17 Europe PMC11 |
2021 |
Homan, C. C., King-Smith, S. L., Lawrence, D. M., Arts, P., Feng, J., Andrews, J., . . . Brown, A. L. (2021). The RUNX1 database (RUNX1db): Establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy. Haematologica, 106(11), 3004-3007. DOI Scopus10 WoS8 Europe PMC4 |
2021 |
Homan, C. C., Venugopal, P., Arts, P., Shahrin, N. H., Feurstein, S., Rawlings, L., . . . Hahn, C. N. (2021). GATA2 deficiency syndrome: a decade of discovery. Human Mutation, 42(11), 1399-1421. DOI Scopus4 WoS4 Europe PMC4 |
2021 |
Samaraweera, S. E., Wang, P. P. S., Li, K. L., Casolari, D. A., Feng, J., Pinese, M., . . . D'Andrea, R. J. (2021). Childhood acute myeloid leukemia shows a high level of germline predisposition. Blood, 138(22), 2293-2298. DOI Scopus4 WoS4 |
2021 |
Homan, C. C., Venugopal, P., Arts, P., Shahrin, N. H., Feurstein, S., Rawlings, L., . . . Hahn, C. N. (2021). Cover, Volume 42, Issue 11. Human Mutation, 42(11). DOI |
2020 |
Venugopal, P., Gagliardi, L., Forsyth, C., Feng, J., Phillips, K., Babic, M., . . . Scott, H. S. (2020). Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss. BMC Medical Genetics, 21(1), 35-1-35-5. DOI Scopus2 WoS2 Europe PMC2 |
2020 |
Brown, A. L., Arts, P., Carmichael, C. L., Babic, M., Dobbins, J., Chong, C. -E., . . . Scott, H. S. (2020). RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML. Blood Advances, 4(6), 1131-1144. DOI Scopus52 WoS50 Europe PMC29 |
2020 |
Brown, A. L., Hahn, C. N., & Scott, H. S. (2020). Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA). Blood, 136(1), 24-35. DOI Scopus37 WoS35 Europe PMC29 |
2020 |
Fox, L. C., Tan, M., Brown, A. L., Arts, P., Thompson, E., Ryland, G. L., . . . Blombery, P. (2020). A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability. British Journal of Haematology, 190(5), e297-e301. DOI Scopus11 WoS10 Europe PMC7 |
2020 |
Brown, A. L., Hahn, C., Hiwase, D., Godley, L. A., & Scott, H. S. (2020). Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis. LEUKEMIA & LYMPHOMA, 61(1), 2 pages. DOI Scopus2 WoS2 Europe PMC1 |
2019 |
Byrne, A. B., Arts, P., Polyak, S. W., Feng, J., Schreiber, A. W., Kassahn, K. S., . . . Scott, H. S. (2019). Identification and targeted management of a neurodegenerative disorder caused by biallelic mutations in SLC5A6. npj Genomic Medicine, 4(1), 1-8. DOI Scopus10 WoS8 Europe PMC7 |
2019 |
Singhal, D., Wee, L. Y. A., Kutyna, M. M., Chhetri, R., Geoghegan, J., Schreiber, A. W., . . . Hiwase, D. K. (2019). The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution. Leukemia, 33(12), 2842-2853. DOI Scopus29 WoS28 Europe PMC15 |
2019 |
Cheah, J. J. C., Brown, A. L., Schreiber, A. W., Feng, J., Babic, M., Moore, S., . . . Scott, H. S. (2019). A novel germline SAMD9L mutation in a family with ataxia-pancytopenia syndrome and pediatric acute lymphoblastic leukemia. Haematologica, 104(7), e318-e321. DOI Scopus12 WoS10 Europe PMC9 |
2019 |
Iacobucci, I., Wen, J., Meggendorfer, M., Choi, J. K., Shi, L., Pounds, S. B., . . . Mullighan, C. G. (2019). Genomic subtyping and therapeutic targeting of acute erythroleukemia. Nature genetics, 51(4), 694-704. DOI Scopus67 WoS68 Europe PMC46 |
2018 |
Al Seraihi, A. F., Rio-Machin, A., Tawana, K., Bödör, C., Wang, J., Nagano, A., . . . Fitzgibbon, J. (2018). GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML. Leukemia, 32(11), 2502-2507. DOI Scopus36 WoS35 Europe PMC25 |
2018 |
Branford, S., Wang, P., Yeung, D. T., Thomson, D., Purins, A., Wadham, C., . . . Hughes, T. P. (2018). Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease. Blood, 132(9), 948-961. DOI Scopus104 WoS99 Europe PMC69 |
2018 |
Beck, D., Thoms, J., Palu, C., Herold, T., Shah, A., Olivier, J., . . . Pimanda, J. (2018). A four-gene lincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients. Leukemia, 32(2), 263-272. DOI Scopus26 WoS24 Europe PMC14 |
2018 |
Chong, C. -E., Venugopal, P., Stokes, P., Lee, Y., Brautigan, P., Yeung, D., . . . Scott, H. (2018). Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes. Leukemia, 32(1), 194-202. DOI Scopus39 WoS37 Europe PMC22 |
2017 |
Carruthers, V., Nicola, M., Venugopal, P., Hahn, C. N., Scott, H. S., & Revesz, T. (2017). Clinical implications of transient myeloproliferative disorder in a neonate without Down syndrome features. Journal of Paediatrics and Child Health, 53(10), 1018-1020. DOI Scopus1 WoS1 Europe PMC1 |
2017 |
Pagani, I. S., Kok, C. H., Saunders, V. A., Van der Hoek, M. B., Heatley, S. L., Schwarer, A. P., . . . Ross, D. M. (2017). A method for next-generation sequencing of paired diagnostic and remission Samples to detect mitochondrial DNA mutations associated with leukemia. The Journal of molecular diagnostics : JMD, 19(5), 711-721. DOI Scopus5 WoS4 Europe PMC4 |
2017 |
Oftedal, B., Ardesjö Lundgren, B., Hamm, D., Gan, P., Holdsworth, S., Hahn, C., . . . Scott, H. (2017). T cell receptor assessment in autoimmune disease requires access to the most adjacent immunologically active organ. Journal of Autoimmunity, 81, 1-10. DOI Scopus5 WoS4 Europe PMC2 |
2017 |
Casolari, D., Nguyen, T., Butcher, C., Iarossi, D., Hahn, C., Bray, S., . . . D'Andrea, R. (2017). A novel, somatic, transforming mutation in the extracellular domain of epidermal growth factor receptor identified in myeloproliferative neoplasm. Scientific Reports, 7(1), 2467-1-2467-9. DOI Scopus5 WoS4 Europe PMC3 |
2017 |
Cheah, J., Hahn, C., Hiwase, D., Scott, H., & Brown, A. (2017). Myeloid neoplasms with germline DDX41 mutation. International Journal of Hematology, 106(2), 163-174. DOI Scopus55 WoS50 Europe PMC37 |
2017 |
Tiong, I., Casolari, D., Moore, S., Nguyen, T., Van Velzen, M., Zantomio, D., . . . Ross, D. (2017). Apparent ‘JAK2-negative’ polycythaemia vera due to compound mutations in exon 14. British Journal of Haematology, 178(2), 333-336. DOI Scopus10 WoS9 Europe PMC3 |
2017 |
Venugopal, P., Moore, S., Lawrence, D., George, A., Hannan, R., Bray, S., . . . Scott, H. (2017). Self-reverting mutations partially correct the blood phenotype in a Diamond Blackfan Anemia patient. Haematologica, 102(12), e506-e509. DOI Scopus19 WoS19 Europe PMC13 |
2017 |
De Sousa, S. M. C., Stowasser, M., Feng, J., Schreiber, A. W., Wang, P., Hahn, C. N., . . . Gagliardi, L. (2017). ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II). Journal of Human Hypertension, 31(12), 857-859. DOI Scopus3 WoS1 Europe PMC3 |
2016 |
Barnett, C., Nataren, N., Klingler-Hoffmann, M., Schwarz, Q., Chong, C., Lee, Y., . . . Scott, H. (2016). Ectrodactyly and lethal pulmonary acinar dysplasia associated with homozygous FGFR2 mutations identified by exome sequencing. Human Mutation, 37(9), 955-963. DOI Scopus24 WoS17 Europe PMC14 |
2016 |
Barnett, C. P., Nataren, N. J., Klingler-Hoffmann, M., Schwarz, Q., Chong, C. E., Lee, Y. K., . . . Scott, H. S. (2016). Cover Image, Volume 37, Issue 9. Human Mutation, 37(9), i. DOI |
2016 |
Ross, D., Altamura, H., Hahn, C., Nicola, M., Yeoman, A., Holloway, M., . . . Scott, H. (2016). Delayed diagnosis leading to accelerated-phase chronic eosinophilic leukemia due to a cytogenetically cryptic, imatinib-responsive TNIP1-PDFGRB fusion gene. Leukemia, 30(6), 1402-1405. DOI Scopus5 WoS5 Europe PMC4 |
2016 |
Lewinsohn, M., Brown, A. L., Weinel, L. M., Phung, C., Rafidi, G., Lee, M. K., . . . Scott, H. S. (2016). Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies. Blood, 127(8), 1017-1023. DOI Scopus136 WoS124 Europe PMC97 |
2016 |
Ling, K., Brautigan, P., Moore, S., Fraser, R., Cheah, P., Raison, J., . . . Scott, H. (2016). Derivation of an endogenous small RNA from double-stranded Sox4 sense and natural antisense transcripts in the mouse brain. Genomics, 107(2-3), 88-99. DOI Scopus14 WoS12 Europe PMC9 |
2016 |
Ling, K., Brautigan, P., Moore, S., Fraser, R., Leong, M., Leong, J., . . . Scott, H. (2016). In depth analysis of the Sox4 gene locus that consists of sense and natural antisense transcripts. Data in Brief, 7, 282-290. DOI Scopus4 Europe PMC2 |
2015 |
Gagliardi, L., Nataren, N., Feng, J., Schreiber, A., Hahn, C., Conwell, L., . . . Scott, H. (2015). Allan-Herndon-Dudley syndrome with unusual profound sensorineural hearing loss. American Journal of Medical Genetics, Part A, 167(8), 1872-1876. DOI Scopus8 WoS8 Europe PMC4 |
2015 |
Hu, Z., Scott, H., Qin, G., Zheng, G., Chu, X., Xie, L., . . . Wei, C. (2015). Revealing missing human protein isoforms based on ab initio prediction, RNA-seq and proteomics. Scientific Reports, 5(1), 10940-1-10940-15. DOI Scopus27 WoS24 Europe PMC16 |
2015 |
Kazenwadel, J., Betterman, K., Chong, C., Stokes, P., Lee, Y., Secker, G., . . . Harvey, N. (2015). GATA2 is required for lymphatic vessel valve development and maintenance. Journal of Clinical Investigation, 125(8), 2979-2994. DOI Scopus140 WoS129 Europe PMC85 |
2015 |
Hahn, C., Venugopal, P., Scott, H., & Hiwase, D. (2015). Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy. Immunological Reviews, 263(1), 257-278. DOI Scopus34 WoS30 Europe PMC27 |
2015 |
Hahn, C., Brautigan, P., Chong, C., Janssan, A., Venugopal, P., Lee, Y., . . . Scott, H. (2015). Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia. Leukemia, 29(8), 1795-1797. DOI Scopus9 WoS9 Europe PMC8 |
2015 |
Hahn, C., Ross, D., Feng, J., Beligaswatte, A., Hiwase, D., Parker, W., . . . Scott, H. (2015). A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone. Leukemia, 29(10), 2101-2104. DOI Scopus23 WoS22 Europe PMC20 |
2014 |
Hiwase, D. K., Hahn, C. N., Babic, M., Moore, S., Butcher, C. M., Kutyna, M. M., . . . Scott, H. S. (2014). Clonal Diversity of Recurrently Mutated Genes in Myelodysplastic Syndromes. BLOOD, 124(21), 3 pages. |
2014 |
Gagliardi, L., Schreiber, A., Hahn, C., Feng, J., Cranston, T., Boon, H., . . . Scott, H. (2014). ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 99(9), E1784-E1792. DOI Scopus82 WoS69 Europe PMC52 |
2014 |
Young, J. A., Ting, K. K., Li, J., Moller, T., Dunn, L., Lu, Y., . . . Gamble, J. R. (2014). Erratum: Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted mirna antagonists of mir-27 (Blood (2012) 122:16 (2911-2919)). Blood, 124(19), 3034. DOI |
2013 |
Shah, S., & Hahn, C. (2013). A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nature Genetics, 45(10), 1226-1231. DOI Scopus213 WoS189 Europe PMC147 |
2013 |
Young, J., Ting, K., Li, J., Moller, T., Dunn, L., Lu, Y., . . . Gamble, J. (2013). Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27. Blood, 122(16), 2911-2919. DOI Scopus50 WoS48 Europe PMC36 |
2012 |
Gagliardi, L., Ling, K., Kok, C., Carolan, J., Brautigan, P., Kenyon, R., . . . Scott, H. (2012). Genome-wide gene expression profiling identifies overlap with malignant adrenocortical tumours and novel mechanisms of inefficient steroidogenesis in familial ACTH-independent macronodular adrenal hyperplasia. Endocrine-Related Cancer, 19(3), 19-23. DOI Scopus6 WoS6 Europe PMC5 |
2012 |
Kazenwadel, J., Secker, G., Liu, Y., Rosenfeld, J., Wildin, R., Cuellar-Rodriguez, J., . . . Harvey, N. (2012). Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood, 119(5), 1283-1291. DOI Scopus206 WoS187 Europe PMC145 |
2012 |
Nguyen, L., Jolly, L., Shoubridge, C., Chan, W., Huang, L., Laumonnier, F., . . . Gecz, J. (2012). Transcriptome profiling of UPF3B/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability. Molecular Psychiatry, 17(11), 1103-1115. DOI Scopus72 WoS69 Europe PMC57 |
2012 |
Hahn, C., & Scott, H. (2012). Spliceosome mutations in hematopoietic malignancies. Nature Genetics, 44(1), 9-10. DOI Scopus49 WoS44 Europe PMC38 |
2011 |
Hahn, C., Chong, C., Carmichael, C., Wilkins, E., Brautigan, P., Li, X., . . . Scott, H. (2011). Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nature Genetics, 43(10), 1012-1019. DOI Scopus438 WoS399 Europe PMC309 |
2011 |
Ling, K., Brautigan, P., Hahn, C., Daish, T., Rayner, J., Cheah, P., . . . Scott, H. (2011). Deep sequencing analysis of the developing mouse brain reveals a novel microRNA. BMC Genomics, 12(1), 1-15. DOI Scopus49 WoS43 Europe PMC34 |
2011 |
Ling, K., Hewitt, C., Beissbarth, T., Hyde, L., Cheah, P., Smyth, G., . . . Scott, H. (2011). Spatiotemporal regulation of multiple overlapping sense and novel natural antisense transcripts at the Nrgn and Camk2n1 gene loci during mouse cerebral corticogenesis. Cerebral Cortex, 21(3), 683-697. DOI Scopus29 WoS27 Europe PMC21 |
2010 |
Carmichael, C., Wilkins, E., Bengtsson, H., Horwitz, M., Speed, T., Vincent, P., . . . Scott, H. (2010). Poor prognosis in familial acute myeloid leukaemia with combined biallelic CEBPA mutations and downstream events affecting the ATM, FLT3 and CDX2 genes. British Journal of Haematology, 150(3), 382-385. DOI Scopus14 WoS11 Europe PMC9 |
2010 |
Coleman, P., Hahn, C., Grimshaw, M., Lu, Y., Li, X., Brautigan, P., . . . Gamble, J. (2010). Stress-induced premature senescence mediated by a novel gene, SENEX, results in an anti-inflammatory phenotype in endothelial cells. Blood, 116(19), 4016-4024. DOI Scopus39 WoS37 Europe PMC35 |
2010 |
Jongmans, M., Kuiper, R., Carmichael, C., Wilkins, E., Dors, N., Carmagnac, A., . . . Hoogerbrugge, N. (2010). Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome. Leukemia, 24(1), 242-246. DOI Scopus72 WoS68 Europe PMC45 |
2009 |
Gamble, J., Sun, W., Li, X., Hahn, C., Pitson, S., Vadas, M., & Bonder, C. (2009). Sphingosine kinase-1 associates with Integrin alpha(V)beta(3) to mediate endothelial cell survival. American Journal of Pathology, 175(5), 2217-2225. DOI Scopus17 WoS14 Europe PMC13 |
2009 |
Ling, K., Hewitt, C., Beissbarth, T., Hyde, L., Ghosal, K., Cheah, P., . . . Scott, H. (2009). Molecular networks involved in mouse cerebral corticogenesis and spatio-temporal regulation of Sox4 and Sox11 novel antisense transcripts revealed by transcriptome profiling. Genome Biology (Online Edition), 10(10), 1-31. DOI Scopus35 WoS31 Europe PMC27 |
2009 |
Li, X., Stankovic, M., Lee, B., Aurrand-Lions, M., Hahn, C., Lu, Y., . . . Gamble, J. (2009). JAM-C Induces endothelial cell permeability through its association and regulation of beta(3) integrins. Arteriosclerosis Thrombosis and Vascular Biology, 29(8), 1200-U101. DOI Scopus38 WoS34 Europe PMC30 |
2009 |
Limaye, V., Xia, P., Hahn, C., Smith, M., Vadas, M., Pitson, S., & Gamble, J. (2009). Chronic increases in sphingosine kinase-1 activity induce a pro-inflammatory, pro-angiogenic phenotype in endothelial cells. Cellular & Molecular Biology Letters, 14(3), 424-441. DOI Scopus30 WoS23 Europe PMC14 |
2008 |
Li, X., Stankovic, M., Bonder, C., Hahn, C., Parsons, M., Pitson, S., . . . Gamble, J. (2008). Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. Blood, 111(7), 3489-3497. DOI Scopus74 WoS68 Europe PMC53 |
2006 |
Young, N., Hahn, C., Poh, A., Dong, C., Wilhelm, D., Olsson, J., . . . Koopman, P. (2006). Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development. Journal of the National Cancer Institute, 98(15), 1060-1067. DOI Scopus79 WoS79 Europe PMC51 |
2006 |
Gamble, J., Xia, P., Hahn, C., Drew, J., Drogemuller, C., Brown, D., & Vadas, M. (2006). Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects. International Journal of Cancer, 118(10), 2412-2420. DOI Scopus75 WoS63 Europe PMC34 |
2005 |
Limaye, V., Li, X., Hahn, C., Xia, P., Berndt, M., Vadas, M., & Gamble, J. (2005). Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members. Blood, 105(8), 3169-3177. DOI Scopus146 WoS141 Europe PMC108 |
2005 |
Hahn, C., Su, Z., Drogemuller, C., Tsykin, A., Waterman, S., Brautigan, P., . . . Gamble, J. (2005). Expression profiling reveals functionally important genes and coordinately regulated signaling pathway genes during in vitro angiogenesis. Physiological Genomics, 22(1), 57-69. DOI Scopus17 WoS15 Europe PMC14 |
2004 |
Su, Z., Hahn, C., Goodall, G., Reck, N., Leske, A., Davy, A., . . . Gamble, J. (2004). A vascular cell-restricted RhoGAP, p73RhoGAP, is a key regulator of angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 101(33), 12212-12217. DOI Scopus37 WoS35 Europe PMC33 |
2004 |
Verrier, E., Wang, L., Wadham, C., Albanese, N., Hahn, C., Gamble, J., . . . Xia, P. (2004). PPARg agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: Role of diacylglycerol kinase. Circulation Research, 94(11), 1515-1522. DOI Scopus93 WoS87 Europe PMC74 |
2004 |
Hime, N., Drew, K., Hahn, C., Barter, P., & Rye, K. (2004). Apolipoprotein E enhances hepatic lipase-mediated hydrolysis of reconstituted high-density lipoprotein phospholipid and triacylglycerol in an isoform-dependent manner. Biochemistry, 43(38), 12306-12314. DOI Scopus20 WoS21 Europe PMC15 |
2004 |
Li, X., Hahn, C. N., Parsons, M., Drew, J., Vadas, M. A., & Gamble, J. R. (2004). Role of protein kinase Cζ in thrombin-induced endothelial permeability changes: Inhibition by angiopoietin-1. Blood, 104(6), 1716-1724. DOI Scopus61 WoS58 Europe PMC51 |
2004 |
Nastasi, T., Bongiovanni, A., Campos, Y., Mann, L., Toy, J. N., Bostrom, J., . . . d'Azzo, A. (2004). Ozz-E3, a muscle-specific ubiquitin ligase, regulates β-catenin degradation during myogenesis. Developmental Cell, 6(2), 269-282. DOI Scopus76 WoS71 Europe PMC64 |
2003 |
Hime, N., Wee, K., Barter, P., & Rye, K. -A. (2003). 3P-0731 In vivo formation of high density lipoproteins containing both apolipoprotein A-I and apolipoprotein A-II in the rabbit. Atherosclerosis Supplements, 4(2), 222. DOI |
2002 |
De Geest, N., Bonten, E., Mann, L., De Sousa-Hitzler, J., Hahn, C., & D'Azzo, A. (2002). Genotype-phenotype correlation in inherited severe insulin resistance. Human Molecular Genetics, 11(12), 1465-1475. DOI Scopus138 Europe PMC76 |
2002 |
de Geest, N., Bonten, E., Mann, L., de Souza-Hitzler, J., Hahn, C., & d'Azzo, A. (2002). Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice. HUMAN MOLECULAR GENETICS, 11(12), 1455-1464. DOI WoS82 Europe PMC61 |
2000 |
Davey, R., Hahn, C., May, B., & Morris, H. (2000). Osteoblast gene expression in rat long bones: Effects of ovariectomy and dihydrotestosterone on mRNA levels. Calcified Tissue International, 67(1), 75-79. DOI Scopus33 WoS33 Europe PMC21 |
1998 |
Rottier, R. J., Hahn, C. N., Mann, L. W., Del Pilar Martin, M., Smeyne, R. J., Suzuki, K., & D'Azzo, A. (1998). Lack of PPCA expression only partially coincides with lysosomal storage in galactosialidosis mice: Indirect evidence for spatial requirement of the catalytic rather than the protective function of PPCA. Human Molecular Genetics, 7(11), 1787-1794. DOI Scopus22 WoS20 Europe PMC13 |
1998 |
Hahn, C. N., Del Pilar Martin, M., Zhou, X. Y., Mann, L. W., & D'Azzo, A. (1998). Correction of murine galactosialidosis by bone marrow-derived macrophages overexpressing human protective protein/cathepsin a under control of the colony-stimulating factor-1 receptor promoter. Proceedings of the National Academy of Sciences of the United States of America, 95(25), 14880-14885. DOI Scopus43 WoS45 Europe PMC24 |
1997 |
Hahn, C. N., Del Pilar Martin, M., Schröder, M., Vanier, M. T., Hara, Y., Suzuki, K., . . . D'Azzo, A. (1997). Generalized CNS disease and massive G(M1)-ganglioside accumulation in mice defective in lysosomal acid β-galactosidase. Human Molecular Genetics, 6(2), 205-211. DOI Scopus131 WoS119 Europe PMC95 |
1996 |
Kerry, D., Dwivedi, P., Morris, H., Omdahl, J., & May, B. (1996). Transcriptional Sygernism Between Vitamin D-Rsponsive Elements in the Rat 25-Hyroxyvitamin D-3 24-Hydroxylase (CYP24) Promotor. Journal of Biological Chemistry, 271(47), 29715-29721. DOI Scopus112 WoS101 Europe PMC66 |
1994 |
Hahn, C. N., Kerry, D. M., Omdahl, J. L., & May, B. K. (1994). Identification of a vitamin D responsive element in the promoter of the rat cytochrome P450<inf>24</inf> gene. Nucleic Acids Research, 22(12), 2410-2416. DOI Scopus65 WoS58 Europe PMC21 |
1993 |
HAHN, C. N., KERRY, D. M., MAY, B. K., & OMDAHL, J. L. (1993). CHARACTERIZATION OF THE PROMOTER REGION FOR THE RAT CYTOCHROME P-45024 GENE(CYP24). JOURNAL OF BONE AND MINERAL RESEARCH, 8, S126. |
1993 |
Dogra, S. C., Hahn, C. N., & May, B. K. (1993). Superinduction by Cycloheximide of Cytochrome P4502H1 and 5-Aminolevulinate Synthase Gene Transcription in Chick Embryo Liver. Archives of Biochemistry and Biophysics, 300(1), 531-534. DOI Scopus19 WoS22 Europe PMC9 |
1993 |
Hahn, C. N., Baker, E., Laslo, P., May, B. K., Omdahl, J. L., & Sutherland, G. R. (1993). Localization of the human vitamin D 24-hydroxylase gene (CYP24) to chromosome 20ql3.2→ql3.3. Cytogenetic and Genome Research, 62(4), 192-193. DOI Scopus24 WoS17 Europe PMC7 |
1991 |
Hahn, C. N., Hansen, A. J., & May, B. K. (1991). Transcriptional regulation of the chicken CYP2H1 gene: Localization of a phenobarbital-responsive enhancer domain. Journal of Biological Chemistry, 266(26), 17031-17039. DOI Scopus43 WoS48 Europe PMC17 |